PYC Financial Statements From 2010 to 2024

Stocks . Australia . 
Stock . PYC Therapeutics
PYC Stock   1.40  0.05  3.45%   
PYC Therapeutics financial statements provide useful quarterly and yearly information to potential PYC Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on PYC Therapeutics financial statements helps investors assess PYC Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting PYC Therapeutics' valuation are summarized below:
Gross Profit
15.8 M
Profit Margin
(1.71)
Market Capitalization
653.3 M
Revenue
22.1 M
Earnings Share
(0.10)
There are currently eighty-six fundamental measures for PYC Therapeutics that can be evaluated and compared over time across peers in the sector. All traders should check out PYC Therapeutics' latest fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

PYC Therapeutics Total Revenue

23.16 Million

Check PYC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PYC Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 51.7 K, Cost Of Revenue of 1.5 M or Depreciation And Amortization of 1.1 M, as well as many indicators such as . PYC financial statements analysis is a perfect complement when working with PYC Therapeutics Valuation or Volatility modules.
  
This module can also supplement various PYC Therapeutics Technical models . Check out the analysis of PYC Therapeutics Correlation against competitors.

PYC Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets95.8 M91.2 M26.7 M
Slightly volatile
Other Current Liabilities1.3 M1.3 M723.9 K
Slightly volatile
Total Current Liabilities9.6 M9.1 M3 M
Slightly volatile
Total Stockholder Equity84.5 M80.5 M23 M
Slightly volatile
Accounts Payable7.9 M7.5 M2.1 M
Slightly volatile
Cash70.2 M66.9 M16 M
Slightly volatile
Net Receivables18.9 M18 M4.3 M
Slightly volatile
Total Liabilities10.7 M10.2 M3.3 M
Slightly volatile
Intangible Assets3.8 M4 M4.3 M
Pretty Stable
Common Stock242.1 M230.6 M87.7 M
Slightly volatile
Property Plant Equipment1.3 M1.2 M664.9 K
Slightly volatile
Property Plant And Equipment Net1.7 M1.6 M718.6 K
Slightly volatile
Non Current Assets Total5.9 M5.6 M2.5 M
Slightly volatile
Cash And Short Term Investments70.2 M66.9 M20 M
Slightly volatile
Common Stock Total Equity105.3 M100.3 M61.7 M
Slightly volatile
Common Stock Shares Outstanding3.1 B3.9 B2.9 B
Slightly volatile
Liabilities And Stockholders Equity95.8 M91.2 M27 M
Slightly volatile
Other Current Assets781.2 K744 K180 K
Slightly volatile
Property Plant And Equipment Gross5.9 M5.6 M1.8 M
Slightly volatile
Total Current Assets89.9 M85.6 M24.5 M
Slightly volatile
Short and Long Term Debt Total699.4 K1.1 M733.2 K
Slightly volatile
Other Liabilities217.5 K207.1 K132 K
Slightly volatile
Long Term Debt822.4 K925.2 K1 M
Slightly volatile
Net Tangible Assets17.3 M27 M14.2 M
Slightly volatile
Net Invested Capital84.5 M80.5 M25.5 M
Slightly volatile
Cash And Equivalents14.1 M17.9 M12.1 M
Slightly volatile
Net Working Capital80.3 M76.5 M23.7 M
Slightly volatile
Capital Stock141.5 M230.6 M93.9 M
Slightly volatile
Other Assets0.860.93.1 K
Slightly volatile
Capital Lease Obligations858.1 K1.1 M796.1 K
Very volatile
Long Term Investments240 K270 K294 K
Slightly volatile

PYC Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Cost Of Revenue1.5 M1.1 M1.6 M
Slightly volatile
Depreciation And Amortization1.1 M1.1 M427.2 K
Slightly volatile
Selling General Administrative2.6 M4.5 M2.6 M
Slightly volatile
Total Revenue23.2 M22.1 M6 M
Slightly volatile
Other Operating Expenses64 M60.9 M18.7 M
Slightly volatile
Research Development59.2 M56.4 M15.5 M
Slightly volatile
Total Operating Expenses64 M60.9 M17.7 M
Slightly volatile
Selling And Marketing Expenses1.1 M1.1 M1.1 M
Very volatile
Interest Income835.8 K796 K194.5 K
Slightly volatile
Reconciled Depreciation471.4 K600.9 K282.1 K
Slightly volatile
Minority Interest365.8 K385 K1.7 M
Slightly volatile

PYC Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures224.6 K307 K245.4 K
Slightly volatile
End Period Cash Flow70.2 M66.9 M16 M
Slightly volatile
Begin Period Cash Flow16.4 M15.6 M8.6 M
Slightly volatile
Depreciation1.1 M1.1 M427.2 K
Slightly volatile
Issuance Of Capital Stock96.7 M92.1 M24.3 M
Slightly volatile
Dividends Paid18.7 M9.4 M21.3 M
Slightly volatile

PYC Fundamental Market Drivers

Cash And Short Term Investments66.9 M

About PYC Therapeutics Financial Statements

PYC Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although PYC Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in PYC Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on PYC Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.3 M1.3 M
Cost Of Revenue1.1 M1.5 M
Total Revenue22.1 M23.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for PYC Stock Analysis

When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY